The injection against the RSV Respiratory Syncytial Virus (Respiratory Syncytial Virus) is part of the National Vaccination Program and is given to babies born from April 1, 2025. 

The RSV

RSV causes respiratory infections, such as colds. The virus is most common in the fall and winter. Especially for young infants, RSV can be dangerous. They may become short of breath or develop pneumonia. 

How the Injection Works

The injection against RSV is not a vaccination but an immunization. The injection contains antibodies against the virus. The baby does not need to produce these antibodies themselves, which is required in a vaccination. The injection provides almost immediate protection, lasting about 6 months. 

The injection works well and there are almost no side effects. Very rarely, babies may develop a rash, the injection site may become briefly red or swollen, or a baby may get a fever.  

In other European countries, the injection is already being administered. There, the number of hospitalizations due to RSV has decreased by 80%. 

Seasonal Injection

RSV is most common in the fall and winter. Babies receive the injection just before or during the season when RSV is most prevalent. The timing of the injection depends on the birth date:

• Babies born from October 1 to March 31 receive the injection within two weeks after birth.
• Babies born from April 1 to September 30 receive the injection in September or October.

Parents receive information from the midwifery care provider, at the consultation office, or from the RIVM. The consultation office arranges the appointment for the injection against RSV.